The interaction between acquired mitochondrial disease and neurodegeneration

Affiliations

Comment

K Harding et al. J Neurol. 2012 Aug.

. 2012 Aug;259(8):1761-3.

doi: 10.1007/s00415-012-6614-3.

¹ Department of Psychological Medicine and Neurology, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.

No abstract available

Comment on

Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease.
Johri A, Calingasan NY, Hennessey TM, Sharma A, Yang L, Wille E, Chandra A, Beal MF. Johri A, et al. Hum Mol Genet. 2012 Mar 1;21(5):1124-37. doi: 10.1093/hmg/ddr541. Epub 2011 Nov 17. Hum Mol Genet. 2012. PMID: 22095692 Free PMC article.
NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury.
Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, Mahad D, Bradl M, van Horssen J, Lassmann H. Fischer MT, et al. Brain. 2012 Mar;135(Pt 3):886-99. doi: 10.1093/brain/aws012. Brain. 2012. PMID: 22366799 Free PMC article.
Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease.
Lin MT, Cantuti-Castelvetri I, Zheng K, Jackson KE, Tan YB, Arzberger T, Lees AJ, Betensky RA, Beal MF, Simon DK. Lin MT, et al. Ann Neurol. 2012 Jun;71(6):850-4. doi: 10.1002/ana.23568. Ann Neurol. 2012. PMID: 22718549 Free PMC article.